QA: Acer Therapeutics Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001069308_2014_Acer_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001069308, Acer Therapeutics Inc

  xvar xval
0 AssetsCurrent 24,767,118
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,295,024
3 remainder_Assets 177,666
4 LiabilitiesCurrent 0
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 5,662,534
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 2,267,302
11 remainder_Revenues 0
12 remainder_NetIncome -9,447,197
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 26,239,808
1 Liabilities 5,662,534
2 Expenses 2,267,302
3 Revenues 0
4 StockholdersEquity 20,577,274
5 NetIncome -11,714,499
6 ComprehensiveNetIncome -11,714,499
7 BaseVar 21,808,420
8 EconomicCapitalRatiobeforeLimitedLiability 2.08
9 EconomicCapitalRatio 3.08

Edgar->Model Mapping

Feature Distribution

Change over Time